7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile

We are 7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile CAS:214470-66-3 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile
CAS.NO:214470-66-3
Synonyms:7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile
7-(3-Chlorpropoxy)-4-hydroxy-6-methoxychinolin-3-carbonitril
7-(3-chloropropoxy)-4-hydroxy-6-methoxyquinoline-3-carbonitrile
7-(3-Chloropropoxy)-4-hydroxy-6-methoxy-3-quinolinecarbonitrile
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 506.4±50.0 °C at 760 mmHg
Molecular Formula C14H13ClN2O3
Molecular Weight 292.718
Flash Point 260.1±30.1 °C
Vapour Pressure 0.0±1.4 mmHg at 25°C
Index of Refraction 1.623
 
Specification:
Appearance:Light yellow to yellow powder
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Bosutinib(CAS:380843-75-4).

7-(3-Chloropropoxy)-6-methoxy-4-oxo-1,4-dihydro-3-quinolinecarbon itrile


Related News: With the improvement of people’s living standards and the aging degree, the demand for medicines has been increasing for a long time. Therefore, the transfer from finished medicines to bulk medicines has greatly promoted the demand for bulk medicines.methyl arachidonate “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.(1R) -2- [2- (4-nitrofenil) etilamino] -1-feniletanol CAS:223673-34-5 “No two studies are the same, and each carries its own unique risks and presents individual challenges, but the aim of CTSuccess is to use the experience we have as a company in supplying materials for thousands of trials to identify the characteristics of a project upfront and highlight potential risk factors that may arise,” said Kristen Devito, Global Director, Catalent Clinical Supply Services.16357-59-8 The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.Optimize the reaction and improve the production process to reduce the production cost. At the same time, strengthen the determination and analysis of impurities to improve product quality.

Related Products
Product Name
(6R,7R)-Benzhydryl 7-amino-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate View Details
1-methoxy-3-nitro-5-(trifluoromethyl)benzene View Details
4-Bromo-2-(trifluoromethyl)benzonitrile View Details
Pentapeptide-18 manufacturer 2,3-Dibromopyridine manufacturer Saccharin manufacturer 4-Amino-1-methylpiperidine manufacturer 2-Methylthio-4,6-pyrimidinedione manufacturer